NCT05177770 Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancer Status TERMINATED Phase PHASE2
NCT05171816 Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05156905 Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer Status TERMINATED Phase PHASE1
NCT05127850 MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer Status COMPLETED Phase NA
NCT05125016 A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT05116579 Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi) Status RECRUITING Phase N/A
NCT05113537 Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT05081193 Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT05011188 FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05005728 XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT04986423 ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer Status RECRUITING Phase PHASE2
NCT04927663 11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression Status TERMINATED Phase PHASE1
NCT04887506 TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer Status COMPLETED Phase PHASE3
NCT04853498 A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets Status TERMINATED Phase PHASE1
NCT04846478 Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04844749 Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent Status TERMINATED Phase PHASE3
NCT04769817 ProsTIC Registry of Men Treated With PSMA Theranostics Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04754191 Enfortumab Vedotin as Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2